ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag intellectual property disease medicine

Intellectual Property and the Challenge of China
Jane Parry(jparry@the-scientist.com) | May 22, 2005 | 6 min read
In July 2004, 12 drug manufacturers in China successfully challenged Pfizer's Viagra patent, in effect gaining the ability to make sildenafil citrate-containing drugs with impunity.
Bespectacled man wearing black shirt with arms folded looks at camera in front of lab cabinet
Neuropathologist John Trojanowski Dies at 75
Lisa Winter | Mar 18, 2022 | 2 min read
His work was pivotal to understanding the mechanisms of neurodegenerative diseases, particularly Alzheimer’s and Parkinson’s.
Notable Science Quotes
The Scientist | Feb 1, 2017 | 2 min read
Intellectual property theft, gun violence, scientific failure, and more
Flux and Uncertainty in the CRISPR Patent Landscape
Aggie Mika | Oct 1, 2017 | 10 min read
The battle for the control of the intellectual property surrounding CRISPR-Cas9 is as storied and nuanced as the technology itself.
Brain cell in purple on a black background. Arc mRNAs are labeled green and are mainly localized in the cell nucleus and in the dendrites.
Short-lived Molecules Support Long-term Memory 
Alejandra Manjarrez, PhD | Jun 6, 2023 | 3 min read
A gene essential for information storage in the brain engages an autoregulatory feedback loop to consolidate memory.
Who Owns CRISPR?
Jenny Rood | Apr 3, 2015 | 5 min read
With one US patent awarded and many other applications under consideration for the popular genome-editing technology, companies are adopting multiple strategies to navigate the complex intellectual property landscape.
Medicines for the World
Suerie Moon and Ellen â??t Hoen and Suerie Moon and Ellen â??t Hoen | Oct 1, 2012 | 5 min read
A global R&D treaty could boost innovation and improve the health of the world’s poor—and rich.
The New Medicine Man
Christopher Smith | Feb 20, 2000 | 9 min read
Courtesy of Zymark Combinatorial Chemistry Products and Services Finding cures for cancer, AIDS, and the plethora of other ailments that plague humans conjures up images from the 1992 movie Medicine Man. In it, Sean Connery as Dr. Robert Campbell treks through the tropical Amazon forests searching for an enigmatic plant that seems to produce a cancer-curing compound. Although scientists may never approach Mother Nature's ability to create novel compounds, new combinatorial chemistry techniques
Personalized Medicine: Seven Keys to Success
Stephen Little | Jan 1, 2006 | 4 min read
Compelling science doesn't always make a good commercial case. Here's how to tell the difference.
Illustration of DNA
Can “Gene Writing” Deliver What Gene Editing Can’t?
Dan Robitzski | Dec 12, 2022 | 10+ min read
A biotech startup called Tessera Therapeutics has made a splash with its claims about the trademarked technology. Is the excitement justified?

Run a Search

ADVERTISEMENT